Cargando…
Blood lactic acid increased by hydroxyurea in a leukemia patient
Autores principales: | Hu, Jing, Luo, Can |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667420/ https://www.ncbi.nlm.nih.gov/pubmed/33224356 http://dx.doi.org/10.5114/aoms.2019.86188 |
Ejemplares similares
-
The use of hydroxyurea pretreatment in chronic myeloid leukemia in the current tyrosine kinase inhibitor era
por: Kockerols, Camille C.B., et al.
Publicado: (2022) -
Hydroxyurea-induced Tooth Discoloration
por: Okuyucu, Muhammed, et al.
Publicado: (2020) -
Melanonychia and skin hyperpigmentation with hydroxyurea therapy
por: Koley, Sankha, et al.
Publicado: (2010) -
Ruxolitinib rechallenge in combination with hydroxyurea is effective in reverting cachexia and reducing blood transfusion demand and splenomegaly symptoms in a patient with primary myelofibrosis
por: Cerchione, Claudio, et al.
Publicado: (2017) -
Menopause in Brazilian women with sickle cell anemia with and without hydroxyurea therapy
por: Queiroz, Ana Mach, et al.
Publicado: (2021)